Latest News Releases
LUXEMBOURG NATIONAL HEALTH FUND APPROVES REIMBURSEMENT OF XIFAXAN® 550*
London, 14 February 2014. 13:00 GMT: Norgine today announced that Luxembourg’s National Health Fund, the Caisse Nationale de Santé (CNS), has approved the reimbursement of XIFAXAN® 550 (rifaximin-α 550mg) for the prevention of the recurrence of hepat More...
view all news releases